Current Challenges and Opportunities of Type 1 Diabetes
A special issue of Biomedicines (ISSN 2227-9059). This special issue belongs to the section "Endocrinology and Metabolism Research".
Deadline for manuscript submissions: closed (31 August 2022) | Viewed by 2125
Special Issue Editor
Special Issue Information
Dear Colleagues,
Due to its increasing importance in society, the decision has been made to dedicate the Special Issue to type 1 diabetes mellitus, a non-communicable disease whose global prevalence has been rising in the last decades, and is estimated to reach 10.9% (700 million) by 2045.
Although basic scientific research related to cutting-edge technologies for the prediction, prevention, and therapy of diabetes has been particularly prevalent, this area in women with type 1 diabetes mellitus during reproductive age has been less extensively discussed. In light of this, the core aim of this Special Issue is to present, in as much detail as possible, the novelty and state of the art related to modern technologies used in women with type 1 diabetes, as a means to personalize and improve the early risk prediction, prevention, and management of pre-pregnancy and pregnancy conditions.
To this end, the Special Issue “Type 1 Diabetes in Women” aims to integrate basic scientific results, and particularly focus on the pathophysiology of the changes in early pregnancy, placental and fetal development, and the impact of diet, supplements and the timely titration of insulin therapy (MDI and insulin pumps), both preconception and during pregnancy. Furthermore, it is essential to discuss the impact of hypoglycemia on the course and outcome of pregnancy, advanced technologies used to improve the regulation of diabetes, and various clinical complications that occur more frequently in type 1 diabetes patients. This Special Issue is expected to provide important information, such as the development or worsening of retinopathy, neurological status, or impaired renal function, emphasizing novel therapies and the choice of modern insulins.
We would like to invite authors to present their recent research results in this Special Issue, and, in doing this, expand the knowledge of our colleagues and motivate other researchers to join us in improving care for women with type 1 diabetes mellitus. For this Special Issue, original research articles and reviews are both welcome.
I look forward to receiving your contributions.
Prof. Dr. Marina Ivanisevic
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biomedicines is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
